MGK..your Madgril is about closest as could be to
Post# of 148102
" That study is meant to clarify the correct dosing of leronlimab in the MASH setting and address the question of potential synergy with Resmetirom, the only currently approved therapy for the treatment of MASH."
As you'd likely say ---- yea, who's asking?
( wink wink )
Lookin good to having been right.